4//SEC Filing
Owens David 4
Accession 0001829126-25-001254
CIK 0001527352other
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 4:33 PM ET
Size
9.8 KB
Accession
0001829126-25-001254
Insider Transaction Report
Form 4
Owens David
DirectorChief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2025-02-26+654,363→ 794,184 totalExercise: $0.89Exp: 2034-06-30→ Common Stock (654,363 underlying) - Award
Stock Option (right to buy)
2025-02-26+139,821→ 139,821 totalExercise: $0.89From: 2025-02-26Exp: 2033-06-30→ Common Stock (139,821 underlying) - Award
Stock Option (right to buy)
2025-02-26+125,000→ 919,184 totalExercise: $2.95From: 2025-02-26Exp: 2029-12-27→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]The option vests in three equal annual installments based on the satisfaction of certain performance criteria for each of the annual periods ending June 30, 2024, 2025 and 2026. The performance criteria for the period ending June 30, 2024 were met, resulting in the vesting of options to purchase 218,121 shares.
Documents
Issuer
Nexalin Technology, Inc.
CIK 0001527352
Entity typeother
Related Parties
1- filerCIK 0001916664
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 4:33 PM ET
- Size
- 9.8 KB